| abstract |
The invention is an oral pharmaceutical composition comprising n a) a tablet core comprising a therapeutically effective amount of 3-fluoro-2-pyridylmethyl-3-(2,2-difluoro-2-(2-pyridyl)ethylamino)-6-chloropyrazin-2-one-1-acetamide, or a pharmaceutically acceptable salt thereof, a water swellable polymer, and a neutralizing agent, and n b) a water insoluble film coating surrounding the tablet core, n wherein the water insoluble film coated tablet core has a plurality of apertures. |